Lin, S., Zhao, X., Li, L., Su, Q., Long, W., Tian, X., . . . Zhang, H. (2025, December). Prospective study of safety, immunogenicity, and efficacy of inactivated COVID-19 vaccine in tuberous sclerosis complex children on sirolimus. Human Vaccines & Immunotherapeutics.
Chicago Style (17th ed.) CitationLin, Sufang, et al. "Prospective Study of Safety, Immunogenicity, and Efficacy of Inactivated COVID-19 Vaccine in Tuberous Sclerosis Complex Children on Sirolimus." Human Vaccines & Immunotherapeutics Dec. 2025.
MLA (9th ed.) CitationLin, Sufang, et al. "Prospective Study of Safety, Immunogenicity, and Efficacy of Inactivated COVID-19 Vaccine in Tuberous Sclerosis Complex Children on Sirolimus." Human Vaccines & Immunotherapeutics, Dec. 2025.
Warning: These citations may not always be 100% accurate.